Copyright
©The Author(s) 2022.
World J Cardiol. Sep 26, 2022; 14(9): 473-482
Published online Sep 26, 2022. doi: 10.4330/wjc.v14.i9.473
Published online Sep 26, 2022. doi: 10.4330/wjc.v14.i9.473
Table 3 Primary and secondary outcomes
Outcome measures | N (%), linearized standard error, 95%CI |
Readmission rate | 12812 (21%), 357.43, [12111-13513] |
Mortality | |
Index cases | 1727 (2.9%), 76.98, [1576-1878] |
Readmission | 1012 (7.9%), 56.61, [901-1123] |
Mean length of stay | |
Index cases | 5.2, 0.05, [5.15-5.32] |
Readmission | 6.4, 0.9, [6.21-6.56] |
Total charges (in USD) | |
Index cases | 40570, 796.7, [39008-42132] |
Readmission | 60822, 1662.9, [57561-64083] |
Total cost (in USD) | |
Index cases | 11234.2, 154.1, [10932-11536] |
Readmission | 16065, 349.7, [15379-16751] |
- Citation: Jha AK, Ojha CP, Krishnan AM, Paul TK. Thirty-day readmission in patients with heart failure with preserved ejection fraction: Insights from the nationwide readmission database. World J Cardiol 2022; 14(9): 473-482
- URL: https://www.wjgnet.com/1949-8462/full/v14/i9/473.htm
- DOI: https://dx.doi.org/10.4330/wjc.v14.i9.473